600351.SS Stock Analysis
60
Neutral
Based on Eyestock quantitative analysis, 600351.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 4,732 full-time employees. The company went IPO on 2002-09-26. The firm mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The firm is also engaged in the wholesaling and trading of pharmaceuticals. The firm distributes its products within domestic market and to overseas markets.